Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis

Schistosoma Haematobium Clinical Trial

Official title:
Randomized Double Blind Clinical Trial in Mali, Comparing the Effectiveness of Artesunate + Sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel in the Treatment of S. Haematobium in Children

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy of praziquantel versus As+SMP (Co-Arinate FDC ®) in the treatment of Schistosoma haematobium in 6-15 year old Malian children. The nul-hypothesis in this study is that the combination of As+SMP is more effective than praziquantel in the treatment of S. haematobium infected children.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Schistosoma Haematobium

Clinical Trial Details

NCT number	NCT00510159
Study type	Interventional
Source	Dafra Pharma
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	August 2007
Completion date	December 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03893097` - Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children	Phase 3
Not yet recruiting	`NCT05941884` - Possible Diagnostic Protein Markers in Schistosoma Related Bladder Diseases.
Withdrawn	`NCT02810613` - Leiden University Medical Center Mini Donor Bank	N/A
Completed	`NCT00870649` - Efficacy of Bilhvax in Association With Praziquantel for Prevention of Clinical Recurrences of Schistosoma Haematobium	Phase 3
Completed	`NCT00713999` - Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar	N/A
Completed	`NCT01163877` - Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or Schistosoma	N/A